<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang X</submitter><funding>the Key Research &amp;amp; Development Projects of Zhejiang Province</funding><funding>the Zhejiang A&amp;amp;F University Scientific Research and Development Fund Project</funding><funding>the Fundamental Research Funds for the Provincial Universities of Zhejiang</funding><funding>the Public Welfare Technology and Application Research Project supported by Sci-ence Technology Department of Zhejiang Province</funding><funding>National Natural Science Foundation of China</funding><funding>the "Pioneer" and "Leading Goose" R&amp;amp;D Program of Zhejiang</funding><funding>the Ability Establishment of Sustainable Use for Valuable Chinese Medicine resources</funding><funding>National College Students Innovation and Entrepreneurship Training Program</funding><pagination>4087-4099</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9497828</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(9)</volume><pubmed_abstract>The escalating prevalence of antibiotic-resistant bacteria has led to a serious global public health problem; therefore, there is an urgent need for the development of structurally innovative antibacterial agents. In our study, a series of biphenyl and dibenzofuran derivatives were designed and synthesized by Suzuki-coupling and demethylation reactions in moderate to excellent yields (51-94% yield). Eleven compounds exhibited potent antibacterial activities against the prevalent antibiotic-resistant Gram-positive and Gram-negative pathogens, among which compounds 4'-(trifluoromethyl)-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6i&lt;/b>) and 5-(9&lt;i>H&lt;/i>-carbazol-2-yl) benzene-1,2,3-triol (&lt;b>6m&lt;/b>) showed the most potent inhibitory activities against methicillin-resistant &lt;i>Staphylococcus aureus&lt;/i> and multidrug-resistant &lt;i>Enterococcus faecalis&lt;/i> with MIC (minimum inhibitory concentration) values as low as 3.13 and 6.25 μg/mL, respectively. Compounds 3',5'-dimethyl-[1,1'-biphenyl]-3,4,4',5-tetraol (&lt;b>6e&lt;/b>), 4'-fluoro-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6g&lt;/b>), and 4'-(trifluoromethyl)-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6i&lt;/b>) showed comparable inhibitory activities with ciprofloxacin to Gram-negative bacterium carbapenems-resistant &lt;i>Acinetobacter baumannii&lt;/i>. Study of the structure-activity relationship indicated that a strong electron-withdrawing group on the A ring and hydroxyl groups on the B ring of biphenyls were beneficial to their antibacterial activities, and for benzo-heterocycles, &lt;i>N&lt;/i>-heterocycle exhibited optimal antibacterial activity. These results can provide novel structures of antibacterial drugs chemically different from currently known antibiotics and broaden prospects for the development of effective antibiotics against antibiotic-resistant bacteria.</pubmed_abstract><journal>Current issues in molecular biology</journal><pubmed_title>Synthesis and Antibacterial Activity Evaluation of Biphenyl and Dibenzofuran Derivatives as Potential Antimicrobial Agents against Antibiotic-Resistant Bacteria.</pubmed_title><pmcid>PMC9497828</pmcid><funding_grant_id>2017FR036</funding_grant_id><funding_grant_id>2060302</funding_grant_id><funding_grant_id>2022C02023</funding_grant_id><funding_grant_id>32101228</funding_grant_id><funding_grant_id>2020C03090</funding_grant_id><funding_grant_id>2021TD001</funding_grant_id><funding_grant_id>GN21B020001</funding_grant_id><funding_grant_id>202110341018, 202010341055</funding_grant_id><pubmed_authors>Fu HY</pubmed_authors><pubmed_authors>He W</pubmed_authors><pubmed_authors>Yang ZC</pubmed_authors><pubmed_authors>Yang SX</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Xiang YT</pubmed_authors><pubmed_authors>Kuang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and Antibacterial Activity Evaluation of Biphenyl and Dibenzofuran Derivatives as Potential Antimicrobial Agents against Antibiotic-Resistant Bacteria.</name><description>The escalating prevalence of antibiotic-resistant bacteria has led to a serious global public health problem; therefore, there is an urgent need for the development of structurally innovative antibacterial agents. In our study, a series of biphenyl and dibenzofuran derivatives were designed and synthesized by Suzuki-coupling and demethylation reactions in moderate to excellent yields (51-94% yield). Eleven compounds exhibited potent antibacterial activities against the prevalent antibiotic-resistant Gram-positive and Gram-negative pathogens, among which compounds 4'-(trifluoromethyl)-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6i&lt;/b>) and 5-(9&lt;i>H&lt;/i>-carbazol-2-yl) benzene-1,2,3-triol (&lt;b>6m&lt;/b>) showed the most potent inhibitory activities against methicillin-resistant &lt;i>Staphylococcus aureus&lt;/i> and multidrug-resistant &lt;i>Enterococcus faecalis&lt;/i> with MIC (minimum inhibitory concentration) values as low as 3.13 and 6.25 μg/mL, respectively. Compounds 3',5'-dimethyl-[1,1'-biphenyl]-3,4,4',5-tetraol (&lt;b>6e&lt;/b>), 4'-fluoro-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6g&lt;/b>), and 4'-(trifluoromethyl)-[1,1'-biphenyl]-3,4,5-triol (&lt;b>6i&lt;/b>) showed comparable inhibitory activities with ciprofloxacin to Gram-negative bacterium carbapenems-resistant &lt;i>Acinetobacter baumannii&lt;/i>. Study of the structure-activity relationship indicated that a strong electron-withdrawing group on the A ring and hydroxyl groups on the B ring of biphenyls were beneficial to their antibacterial activities, and for benzo-heterocycles, &lt;i>N&lt;/i>-heterocycle exhibited optimal antibacterial activity. These results can provide novel structures of antibacterial drugs chemically different from currently known antibiotics and broaden prospects for the development of effective antibiotics against antibiotic-resistant bacteria.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-21T14:38:06.961Z</modification><creation>2025-04-21T14:38:06.961Z</creation></dates><accession>S-EPMC9497828</accession><cross_references><pubmed>36135192</pubmed><doi>10.3390/cimb44090280</doi></cross_references></HashMap>